Kiora Pharmaceuticals (KPRX) Earnings Date & Reports
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more
KPRX is expected to report earnings to rise 52.94% to -51 cents per share on November 06
Q3'26
Est.
$-0.52
Q2'26
Beat
by $0.17
Q1'26
Missed
by $0.09
Q4'25
Missed
by $1.50
Q3'25
Beat
by $0.07
The last earnings report on August 07 showed earnings per share of -34 cents, beating the estimate of -50 cents. With 716.00 shares outstanding, the current market capitalization sits at 11.86M.